Genentech

Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
BioSpace
Wed, 10/4/23 - 09:41 am
Roche
Genentech
clinical trials
Evrysdi
SMA
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream
Fierce Biotech
Wed, 09/20/23 - 08:32 am
Genentech
PeptiDream
drug discovery
biobucks
peptides
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Roche
Genentech
divarasib
KRAS inhibitors
solid tumors
clinical trials
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Genentech
Blueprint Medicines
Gavreto
non-small cell lung cancer
Genentech CEO Hardy warns of 'unintended consequences' from the Inflation Reduction Act
Fierce Pharma
Fri, 07/7/23 - 06:57 am
Genentech
Pharma CEOs
Alexander Hardy
Inflation Reduction Act
Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees
Time
Wed, 07/5/23 - 10:39 am
Genentech
Women's Health
menopause
employee benefits
Four-Year Follow-Up Data for Genentech’s Evrysdi Show Continued Increase in Number of Children With a Severe Form of Spinal ​Muscular ​Atrophy (SMA)​ Able to Sit, Stand and Walk
BioSpace
Mon, 07/3/23 - 11:38 am
Genentech
spinal muscular atrophy
SMA
Evrysdi
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Merck
Inflation Reduction Act
legal
drug pricing
Biogen
Novartis
Genentech
BIO 2023
Roche looking to sell or shut down California biologic drug plant
Reuters
Thu, 06/1/23 - 11:21 am
Roche
Genentech
California
drug manufacturing
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Genentech opens up eye patients’ world with Vabysmo
Medical Marketing and Media
Thu, 04/20/23 - 11:40 pm
Genentech
Vabysmo
wet age-related macular degeneration
DTC ads
FDA Green Lights Roche's Polivy in First-Line DLBCL
BioSpace
Thu, 04/20/23 - 10:45 am
Roche
Genentech
Polivy
diffuse large B-cell lymphoma
FDA
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Genentech turns out lights at first commercial biologics plant, laying off 265 staffers
Fierce Pharma
Thu, 03/23/23 - 09:10 pm
Genentech
Roche
biologics
San Francisco
California
layoffs
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Wed, 03/22/23 - 10:07 am
Genentech
EpiBiologics
protein degradation
FDA advisers question efficacy of Roche’s Polivy in first line LBCL
BioSpace
Wed, 03/8/23 - 11:30 am
Roche
Genentech
Polivy
LBCL
large B-cell lymphoma

Pages